-
Mashup Score: 3
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new research published in Nature.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5
Nature – Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Risk Score Helps Identify Patients With CH at High Risk of Myeloid Malignancy | ASH Clinical News | American Society of Hematology - 7 month(s) ago
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Clonal hematopoiesis (CH) is relatively common, with up to 15% of adults age 60 and older estimated to have one of two CH conditions: CH of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). The rate of diagnosis of these two conditions is steadily increasing. CH is associated with an increased risk of developing myeloid blood cancers but, for most patients, this risk is
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Blood Podcast – Season 6, Episode 5 | Blood | American Society of Hematology Ventricular arrhythmias in sickle cell anemia, molecular heterogeneity of pediatric lymphoproliferative disorders, the role of the bone marrow microenvironment in myeloid disorders In this week’s episode, we’ll learn more about ventricular arrhythmias in sickle cell anemia, discuss the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders, and uncover…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review - 8 month(s) ago
This review summarises the cytomorphological and immunophenotypical alterations characteristic of myeloid neoplasms with defining genetic alterations, including the examples in the image. These cytol…
Source: onlinelibrary.wiley.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Ever wondered what phenotypic clues predict underlying cytogenetic/genetic abnormalities in #myeloid neoplasms? Hopefully this review can be a handy resource! check it out here: https://t.co/mXAR0B7jYS #OpenAccess #leusm @cullen_lilley @sanamloghavi via @CytopathologyJ https://t.co/m6nhD5gZ7U https://t.co/rTvmZDMCrd https://t.co/EnFRVvAl64
-
-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0A backpack full of multiple sclerosis therapy - 11 month(s) ago
A cell therapy using myeloid cells bound to drug delivery microparticles reduces disease burden in a preclinical multiple sclerosis model
Source: Wyss InstituteCategories: Healthcare Professionals, Latest HeadlinesTweet-
A backpack full of #multiplesclerosis therapy https://t.co/6v4ZWQrYWy via @wyssinstitute A backpack-based #myeloid #celltherapy for multiple sclerosis | Proceedings of the National Academy of Sciences https://t.co/EHEf2w8UBj #MS #Autoimmune #EAE #Biomaterials #IL4 "We propose… https://t.co/s9b7VzIoQQ https://t.co/2wWuRLt7Yg
-
-
Mashup Score: 0
Josep Carreras Distinguished Lecture Dr. Elli Papaemmanuil Memorial Sloan Kettering Cancer Center. New York, USA. “Precision oncology in myeloid malignancies” The Host of this webinar is Manel Esteller.
Source: ZoomCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
Cell Symposium: Cell Symposia: Myeloid Cells: From Development to Function and Dysfunction
Source: www.cell-symposia.comCategories: Allergy-Immunology, Latest HeadlinesTweet
💬🚨"This research proves for the first time that targeting #Myeloid cells can shrink tumours. This suggests we have an entirely new way to treat #ProstateCancer on the horizon.'' - Prof Johann De Bono, Professor in Experimental #CancerMedicine https://t.co/aFlNlrrVi3 https://t.co/05P6HUkaYR